Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You?
When you think of coronavirus vaccines using messenger RNA (mRNA), you probably think Pfizer and Moderna. The two companies burst into the forefront with mRNA technology last year, and since then, they've vaccinated more than 103 million and 69 million Americans, respectively.
But Pfizer and Moderna may not be the only players in the world of mRNA coronavirus vaccines for very long. Superstar-investor Cathie Wood has her eye on a much smaller player that aims to apply for emergency use authorization in Vietnam this year. In fact, the founder and CEO of Ark Invest recently bought shares in this biotech company.
Now the question is: Should you follow Wood and scoop up shares of this underdog? Let's take a look.
Source Fool.com
